NovoCure Ltd
Develops a non-invasive cancer therapy using electric fields to disrupt solid tumors.
NVCR | US
Overview
Corporate Details
- ISIN(s):
- JE00BYSS4X48
- LEI:
- Country:
- United States of America
- Address:
- NO. 4 THE FORUM, 0 ST. HELIER
- Website:
- https://www.novocure.com/
Description
NovoCure Ltd. is a global oncology company focused on developing and commercializing its proprietary cancer therapy platform, Tumor Treating Fields (TTFields). This non-invasive therapy utilizes electric fields tuned to specific frequencies to disrupt the division of solid tumor cancer cells, inhibiting tumor growth and causing cell death. The treatment is delivered to patients using a portable, wearable medical device. NovoCure's primary mission is to extend survival in some of the most aggressive forms of cancer. Its technology is commercially available for certain brain cancers and is under late-stage clinical investigation for various other solid tumors, including pancreatic, non-small cell lung, and ovarian cancers.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all NovoCure Ltd filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for NovoCure Ltd
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for NovoCure Ltd via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
